Related Experiment Video
Updated: Aug 9, 2026

Induction and Assessment of Class Switch Recombination in Purified Murine B Cells
Published on: August 14, 2010
CD45 controls interleukin-4-mediated IgE class switch recombination in human B cells through its function as a Janus
Takechiyo Yamada1, Daocheng Zhu, Andrew Saxon
1Hart and Louis Laboratory, Division of Clinical Immunology, Department of Medicine, UCLA School of Medicine, Los Angeles, California 90095-1680, USA.
Insights
CD45 negatively regulates IgE class switching in human B cells by dephosphorylating JAK kinases. This finding suggests CD45 as a potential drug target for allergic diseases.
Area of Science:
- Immunology
- Cell Signaling
Background:
- CD45 is a protein tyrosine phosphatase crucial for receptor signaling.
- Its role in immunoglobulin (Ig) class switching, particularly to IgE, in human B cells is not fully understood.
Purpose of the Study:
- To investigate the regulatory role of CD45 in Ig class switching to IgE in human B cells.
- To determine the relationship between CD45's JAK phosphatase activity and its effect on IgE class switching.
Main Methods:
- Utilized a switch recombination vector assay in Ramos 2G6 human B cells.
- Examined Ig epsilon germ-line transcription and Smu-Sepsilon switch recombination in primary human B cells.
- Assessed the dephosphorylation of JAK kinases and STAT6 by CD45.
Main Results:
- Anti-CD45 triggering inhibited interleukin-4 + anti-CD40-induced switch recombination and IgE class switching.
- CD45 dephosphorylated JAK1, JAK3, and STAT6, but not stress-activated/mitogen-activated protein kinases.
- Recombinant CD45 directly dephosphorylated JAK1 and JAK3 in vitro, confirming its JAK phosphatase activity.
Conclusions:
- CD45 functions as a JAK phosphatase in human B cells.
- This activity is directly linked to the negative regulation of IgE class switch recombination.
- CD45 represents a potential therapeutic target for modulating IgE levels in allergic diseases.
Abstract:
CD45 plays a critical regulatory role in receptor signaling through its protein tyrosine phosphatase and Janus kinase (JAK) phosphatase activities. To investigate whether CD45 also plays a regulatory role in Ig class switching in human B cells, we examined the effects of CD45 triggering on Ig class switching to IgE and its relationship with CD45 JAK phosphatase activity. Anti-CD45 triggering of CD45 significantly inhibited interleukin-4 + anti-CD40-induced switch recombination in a switch recombination vector assay in stably transfected Ramos 2G6 human B cells, as well as Ig epsilon germ-line transcription and Smu-Sepsilon switch recombination in primary human B cells. These negative regulatory effects on Ig class switching were concomitant with the ability of CD45 to dephosphorylate the induced phosphorylation of JAK1, JAK3, and signal transducer and activator of transcription 6, but not on stress-activated/mitogen-activated protein kinases. We also showed that phosphorylated JAK1 and JAK3 were directly dephosphorylated by recombinant CD45 in vitro. These results indicate that CD45 is able to function as JAK phosphatase in human B cells and that this activity is directly associated with the negative regulation of the class switch recombination to IgE. CD45 may be an appropriate target drug for modulating IgE in allergic diseases.
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Inhibition of Cdk Activity
Lineage Commitment
The JAK-STAT Signaling Pathway
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...

